Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
about
Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterolAccurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 geneChromosome 21 and down syndrome: from genomics to pathophysiologyLRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol exportABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytesSterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol statusInhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol effluxIntracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytesEnlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression.The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health StudyThe ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout micemiR-33 links SREBP-2 induction to repression of sterol transporters.Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.High-density lipoprotein and atherosclerosis: Roles of lipid transporters.ABCA1: regulation, trafficking and association with heteromeric proteins.Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.Regulation of ABCA1 functions by signaling pathwaysThe ins and outs of reverse cholesterol transport.ABCA1 and atherosclerosis.Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Genomic profiling in nuclear receptor-mediated toxicity.Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism.Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.Hepatic ABC transporters and triglyceride metabolism.ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.Oxysterols trigger ABCA1-mediated basolateral surfactant efflux.Increased ABCA1 activity protects against atherosclerosis.Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts.Upregulation of surfactant synthesis triggers ABCA1-mediated basolateral phospholipid efflux.The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility.Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides.Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1.Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated PlateletsIntestinal ABCA1 directly contributes to HDL biogenesis in vivoLXR as a novel antithrombotic targetLiver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions
P2860
Q24337975-132CF0C0-B681-408E-808D-0A5F275A4263Q25255858-D497B966-6910-464A-8102-ACD957027E30Q28290257-E27B3885-2E8D-4581-817D-EA84219CF662Q28506509-BDF6CEEA-869F-4F00-9BAA-AC7B76DE2CBFQ28569109-86E9BAF4-1936-44E3-AC12-68C6BF720116Q28569337-EA15EDA4-A96C-4B34-A889-042A9C904A64Q28588482-99410E3F-6790-4167-B2BA-4A3437EF14ADQ28592498-3CDDF969-73E9-4C41-98B8-3F0A7C106859Q30979037-8D71D808-3E93-434A-846A-82154594383DQ33683878-13856F14-0701-4EE5-88F7-046E84E9DCF9Q33897937-46686742-34D9-4E45-B3A9-7214A544E367Q33981907-199D9C6D-E128-4E64-9BEB-A8715D48D13BQ34231924-F6652EB4-AE6A-4C68-A525-0DD1037D06C0Q34404454-AA654200-8293-46CA-965D-CE4696D0F55DQ35009337-9288ED54-21A7-459E-B641-F90EA5E238BDQ35625936-B51ACBC0-FD24-45E6-9A3B-84B6A67AD174Q35626943-65AD46E8-63C7-4816-9BE6-3544F4D08B50Q35761322-593B093C-B6C1-44E0-A842-5FD010EE9FA7Q36192289-AE4C921C-1E67-4C52-A296-B693EE0FEFF3Q36314862-805ADBE0-AC79-4E1E-9A72-4F62649A099EQ36383616-AF468040-DD1A-4372-8C6E-4E82A16502AAQ36448521-8D6C4129-1DCE-4768-835F-2C8DF5708B81Q36846922-0045699F-A349-4F1A-A390-F990A2855096Q37350799-AEFA78DA-B073-4CAF-8E13-AE9C073FD917Q37985757-B47F449A-28BB-46EC-8B43-9C0175ABB5B4Q38001336-4AC70B05-C690-464A-9511-6E4BF0C361FCQ38310381-260CE031-D589-4577-BB34-860F59510ED5Q38343286-4776CA1C-B8F2-412E-9345-8907A1EA451BQ39738088-D1EAC611-99B1-40AB-B814-B28795A4F289Q40528833-2045A2F6-29D0-42A2-A137-59F86CC0BA2EQ40542666-4DE0E2A9-ED7D-4158-A3D5-6919D1857D06Q40577606-C4C4F8E0-E8AA-4EB1-B8B3-EF8A56BCD36CQ40602780-8EF38769-5AF1-4D3D-BA6E-B86164F7EACFQ40638196-0881FBBB-BE79-4D2F-8ABE-69E220DDC2F1Q40650146-C4A460EB-0A3A-46F9-A00E-568199EB962EQ40658862-845A4ACA-4B5A-4B99-A969-9D9E54F8687AQ41118234-26279655-3478-49D4-B24B-3A09A2014E29Q41896773-0B2258AB-3731-4EAF-A8C0-949A896E2459Q41969289-270F5583-2115-4B61-842F-A1796F0189C8Q42071320-ABDB7B49-639F-48A2-BDB0-4FBC7E239238
P2860
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Human ABCA1 BAC transgenic mic ...... response elements in intron 1.
@en
type
label
Human ABCA1 BAC transgenic mic ...... response elements in intron 1.
@en
prefLabel
Human ABCA1 BAC transgenic mic ...... response elements in intron 1.
@en
P2093
P2860
P50
P356
P1476
Human ABCA1 BAC transgenic mic ...... response elements in intron 1
@en
P2093
A Brooks-Wilson
B R Leavitt
C L Wellington
P2860
P304
33969-33979
P356
10.1074/JBC.M102503200
P407
P577
2001-06-21T00:00:00Z